
BEFORE & AFTER
RELIABLE RESULTS ANYWHERE ON THE BODY
Symptoms illustrated. Not an actual patient.
RELIEF PATIENTS CAN SEE AND FEEL
Review clinical trial photos of patients with atopic dermatitis treated with ZORYVE
Popliteal Fossa
AGE 32, FEMALE
Baseline vIGA-AD = 3



Actual clinical trial patient
FACIAL
AGE 9, FEMALE
Baseline vIGA-AD = 3



Actual clinical trial patient
Hand
AGE 11, FEMALE
Baseline vIGA-AD = 3



Actual clinical trial patient
Neck
AGE 51, MALE
Baseline vIGA-AD = 3



Actual clinical trial patient
Trunk
AGE 22, MALE
Baseline vIGA-AD = 3



Actual clinical trial patient
Wrist
AGE 16, FEMALE
Baseline vIGA-AD = 3



Actual clinical trial patient
vIGA-AD 4 = Severe, 3 = Moderate, 2 = Mild, 1 = Almost Clear, 0 = Clear